Central venous catheter-associated bloodstream infections in pediatric hematology-oncology patients and effectiveness of antimicrobial lock therapy

被引:23
|
作者
Tsai, Hsing-Chen [1 ,5 ]
Huang, Li-Min [1 ]
Chang, Luan-Yin [1 ]
Lee, Ping-Ing [1 ]
Chen, Jong-Ming [2 ]
Shao, Pei-Lan [1 ]
Hsueh, Po-Ren [2 ]
Sheng, Wang-Huei [3 ]
Chang, Yu-Ching [4 ]
Lu, Chun-Yi [1 ]
机构
[1] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Div Pediat Infect Dis,Dept Pediat, Taipei 10764, Taiwan
[2] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Lab Med, Taipei 10764, Taiwan
[3] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Ctr Infect Control, Taipei 10764, Taiwan
[4] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Nursing, Taipei 10764, Taiwan
[5] New Taipei City Hosp, Dept Pediat, New Taipei City, Taiwan
关键词
antimicrobial lock therapy; bloodstream infection; central catheter; hematology-oncology; pediatric; ANTIBIOTIC LOCK; HICKMAN CATHETERS; CANCER-PATIENTS; ACCESS DEVICES; CHILDREN; CHLORHEXIDINE; EPIDEMIOLOGY; SURVEILLANCE; PREVENTION; LEUKEMIA;
D O I
10.1016/j.jmii.2014.07.008
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Central line-associated bloodstream infection (CLABSI) is a serious complication in hematology-oncology patients. This study aimed to analyze the prevalence of CLABSI and the effectiveness of antimicrobial lock therapy (ALT) in pediatric patients. Methods: BSIs of all pediatric hematology-oncology patients admitted to a children's hospital between January 2009 and December 2013 were reviewed. The United States National Healthcare Safety Network and Infectious Diseases Society of America guidelines were used to define CLABSI and catheter-related BSI (CRBSI). The incidence, laboratory and microbiology characteristics, poor outcome, and effectiveness of ALT were analyzed. Results: There were 246 cases of CLABSI in 146 patients (mean age, 10.0 years), including 66 (26.8%) cases of CRBSI. The incidence of CLABSI was 4.49/1000 catheter-days, and the infection was responsible for 32.9% of the complications these patients developed and 9.3% of contributable mortality. Patients with acute myeloid leukemia had the highest infection density (5.36/1000 patient-days). Enterobacteriaceae (40.2%) and coagulase-negative staphylococci (CoNS; 20.7%) were the predominant pathogens. In multivariate analysis, older age, male sex, elevated C-reactive protein, acute lymphoblastic leukemia, and candidemia were associated with poor outcome. The success rate of ALT was 58.6% (17/29) for the treatment of CoNS and 78.3% (29/37) for Enterobacteriaceae infections. Patients with candidemia (n = 18) had the highest mortality (33.4%) and catheter removal rate (66.7%). Chlorhexidine as the disinfectant decreased the 1-year CLABSI rate from 13.7/1000 to 8.4/1000 catheterdays (p = 0.02). Conclusion: CoNS and Enterobacteriaceae are the predominant pathogens in CLABSI among pediatric hematology-oncology patients. ALT is effective and showed no significant side effect. New disinfection practice and infection control measures can decrease CLABSI. Copyright (C) 2014, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights reserved.
引用
收藏
页码:639 / 646
页数:8
相关论文
共 50 条
  • [1] Catheter-associated Bloodstream Infections in Pediatric Hematology-Oncology Patients
    Celebi, Solmaz
    Sezgin, Melike Evim
    Cakir, Deniz
    Baytan, Birol
    Demirkaya, Metin
    Sevinir, Betul
    Bozdemir, Sefika Elmas
    Gunes, Adalet Meral
    Hacimustafaoglu, Mustafa
    [J]. PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2013, 30 (03) : 187 - 194
  • [2] Catheter-associated bloodstream infections in pediatric hematology-oncology patients - Factors associated with catheter removal and recurrence
    Adler, A
    Yaniv, I
    Solter, E
    Freud, E
    Samra, Z
    Stein, J
    Fisher, S
    Levy, I
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2006, 28 (01) : 23 - 28
  • [3] Central venous catheter-associated bloodstream infections in pediatric oncology home care
    Shah, SS
    Manning, ML
    Leahy, E
    Magnusson, M
    Rheingold, SR
    Bell, LM
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2002, 23 (02): : 99 - 101
  • [4] Cure of implantable venous port-associated bloodstream infections in pediatric hematology-oncology patients without catheter removal
    Rubin, LG
    Shih, S
    Shende, A
    Karayalcin, G
    Lanzkowsky, P
    [J]. CLINICAL INFECTIOUS DISEASES, 1999, 29 (01) : 102 - 105
  • [5] Should lock therapy always be avoided for central venous catheter-associated fungal bloodstream infections?
    Viale, P
    Petrosillo, N
    Signorini, L
    Puoti, M
    Carosi, G
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 33 (11) : 1947 - 1948
  • [6] Central venous catheter-associated bloodstream infections
    Newman, Nitza
    Issa, Amal
    Greenberg, David
    Kapelushnik, Joseph
    Cohen, Zahavi
    Leibovitz, Eugene
    [J]. PEDIATRIC BLOOD & CANCER, 2012, 59 (02) : 410 - 414
  • [7] A Local Experience of Antibiotic Lock Therapy as an Adjunctive Treatment for Central Venous Catheter-Related Bloodstream Infections in Pediatric Oncology and Hematology Patients
    de Frutos Porras, Elena
    Cobo-Vazquez, Elvira
    Lobo, Alicia Hernanz
    del Mar Santos Sebastian, Maria
    Fernandez, Elia Perez
    Colino, Carmen Garrido
    Cela, Elena
    Gomez, Maria Luisa Navarro
    [J]. CHILDREN-BASEL, 2024, 11 (08):
  • [8] Preemptive Ethanol Lock Therapy in Pediatric Hematology/Oncology Patients With Catheter-Associated Bloodstream Infection: Impact on Length of Stay, Cost, and Catheter Salvage
    McGrath, Eric
    Du, Wei
    Rajpurkar, Madhvi
    [J]. CLINICAL PEDIATRICS, 2018, 57 (03) : 285 - 293
  • [9] Central Venous Catheter Flushing and an Outbreak of Bacteremia among Pediatric Hematology-Oncology Patients
    Cesaro, Simone
    Chinello, Pierangelo
    Cavaliere, Mara
    Rossi, Lucia
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2010, 31 (10): : 1098 - 1100
  • [10] CENTRAL VENOUS CATHETER-RELATED INFECTIONS IN PEDIATRIC HEMATOLOGY-ONCOLOGY PATIENTS - ROLE OF HOME AND HOSPITAL MANAGEMENT
    RIZZARI, C
    PALAMONE, G
    CORBETTA, A
    UDERZO, C
    VIGANO, EF
    CODECASA, G
    [J]. PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1992, 9 (02) : 115 - 123